TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31167050

Group type: EXPERIMENTAL
Intervention: Azithromycin (twice yearly for 2 years, followed by additional distributions in MORDOR II)
Number of subjects: 594

Group type: EXPERIMENTAL
Intervention: Azithromycin (additional distributions in MORDOR II)
Number of subjects: 594

Group type: COMPARATOR
Intervention: Placebo (first 2 years in MORDOR I)
Number of subjects: 594

Group type: EXPERIMENTAL
Intervention: Azithromycin (continued for an additional year)
Number of subjects: 594
Study: 28571671

Group type: EXPERIMENTAL
Intervention: Bifidobacterium breve strain BBG‐001 (probiotic)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Early antibiotic exposure
Number of subjects: 103
Study: 26028347

Group type: EXPERIMENTAL
Intervention: HELP-COPD
Number of subjects: 32

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 32
Study: 24004465

Group type: EXPERIMENTAL
Intervention: PCV13
Number of subjects: 619

Group type: COMPARATOR
Intervention: PCV7
Number of subjects: 619
Study: 22068177

Group type: EXPERIMENTAL
Intervention: P5: alkaline hypochlorite for 10 minutes
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: P6: home use chlorine solution (Q'boa® at 0.45% for 10 min)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: P4: brushing with water and liquid soap for 40 s
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: P3: cleaning with alkaline peroxide (Corega Tabs®) for 30 min
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: P2: cleaning with alkaline peroxide (Corega Tabs®) for 5 min
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: P1: washing under running water for 20 s
Number of subjects: 15
Study: 19816370

Group type: EXPERIMENTAL
Intervention: Bottle-feeding with the usual nipple (G1, N = 42)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Feeding with a spoon, cup, or syringe (G2, N = 40)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Bottle-feeding (G1)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Feeding with a spoon, cup, or syringe (G2)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Both groups (G1 and G2)
Number of subjects: 82
Study: 17013635

Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (capsules containing an amino acid mixture specifically lacking tryptophan)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo capsules containing lactose
Number of subjects: 0
Study: 12723103

Group type: EXPERIMENTAL
Intervention: Float-Brush
Number of subjects: 42

Group type: COMPARATOR
Intervention: Techno-Brush
Number of subjects: 42

Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 42
Study: 11045790

Group type: EXPERIMENTAL
Intervention: fenretinide (200 mg day p.o. for 24 months)
Number of subjects: 99

Group type: COMPARATOR
Intervention: no intervention (control)
Number of subjects: 99
Study: 9253394

Group type: EXPERIMENTAL
Intervention: Adenoidectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 0
Study: 8487136

Group type: EXPERIMENTAL
Intervention: EMLA (topical anesthetic)
Number of subjects: 73
Study: 30971236

Group type: EXPERIMENTAL
Intervention: Further Enabling Care at Home (FECH) program
Number of subjects: 21
Study: 28532509

Group type: EXPERIMENTAL
Intervention: Individualized dialysis temperature (IDT) of 0.5 °C below body temperature
Number of subjects: 18

Group type: COMPARATOR
Intervention: Standard dialysis temperature of 36.5 °C
Number of subjects: 18
Study: 25869467

Group type: EXPERIMENTAL
Intervention: Topical antibiotic and steroid combination (ofloxacin 0.26% and dexamethasone 0.053% nasal drops) for 10 days, administered intranasally (5 drops in each nostril/8 hours)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Oral antibiotic alone (amoxicillin 90 mg/kg)
Number of subjects: 40
Study: 23261786

Group type: EXPERIMENTAL
Intervention: 6-month-olds; identical music and room on test day to learning environment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 9-month-olds; change in music allowed
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 12-month-olds; change in room and music allowed
Number of subjects: 0
Study: 21612429

Group type: EXPERIMENTAL
Intervention: Guarana 50 mg by mouth twice daily
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 19824119

Group type: EXPERIMENTAL
Intervention: Transnasal butorphanol (n = 30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intramuscular meperidine (n = 30)
Number of subjects: 60
Study: 16805714

Group type: EXPERIMENTAL
Intervention: Biological agents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination regimens with chemotherapy and/or biological therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cytotoxic chemotherapy
Number of subjects: 0
Study: 15541858

Group type: EXPERIMENTAL
Intervention: Nonabsorbable sutures (group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Prolene mesh (group B)
Number of subjects: 60
Study: 11391692

Group type: EXPERIMENTAL
Intervention: General method for generating new distributions with an intensity function
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Families of distributions based on the Pareto distribution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Updating procedures similar to Kalman filter
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Updating procedures similar to copulas
Number of subjects: 0
Study: 9602319

Group type: EXPERIMENTAL
Intervention: Tear Ferning Test (TFT) performed at enrollment and after 1 month (T1)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Tear Ferning Test (TFT) considering only type I ferning
Number of subjects: 116
Study: 8167785

Group type: EXPERIMENTAL
Intervention: Hydration treatment
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo/control treatment
Number of subjects: 6
Study: 2964981

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Intensified conventional treatment (ICT) using the NovoPen
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Questionnaire results
Number of subjects: 21
Study: 30301187

Group type: EXPERIMENTAL
Intervention: SOC plus vaccination with Audencel (weekly intranodal application in weeks 7 to 10, followed by monthly intervals)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: SOC plus vaccination with Audencel
Number of subjects: 76

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 76
Study: 26879587

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (20 IU twice daily)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 28
Study: 25867659

Group type: EXPERIMENTAL
Intervention: Increased physical and nutritional rehabilitation plus information delivered during the post-ICU hospital stay by dedicated rehabilitation assistants.
Number of subjects: 240

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Increased physical and nutritional rehabilitation plus information provision (intervention group).
Number of subjects: 240
Study: 23993440

Group type: EXPERIMENTAL
Intervention: More frequent exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Less frequent exercise
Number of subjects: 0
Study: 20573800

Group type: EXPERIMENTAL
Intervention: Atkins
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: LEARN
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: Ornish
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: Zone
Number of subjects: 291
Study: 18637156

Group type: EXPERIMENTAL
Intervention: 0.1 mg of imidafenacin/day
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: 0.2 mg of imidafenacin/day
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: 0.5 mg of imidafenacin/day
Number of subjects: 401

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 401
Study: 17436825

Group type: EXPERIMENTAL
Intervention: ER-minocycline 1 mg/kg
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: ER-minocycline 2 mg/kg
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: ER-minocycline 3 mg/kg
Number of subjects: 233

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 233
Study: 14601274

Group type: EXPERIMENTAL
Intervention: Sutured technique of catheter fixation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Tunnelled technique
Number of subjects: 50
Study: 10992826

Group type: EXPERIMENTAL
Intervention: Tramadol (100 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 14
Study: 8798927

Group type: EXPERIMENTAL
Intervention: 100 mg of tramadol (Protradon and Tramal)
Number of subjects: 12
Study: 1335441

Group type: EXPERIMENTAL
Intervention: GU‐052 (3 x 4 g daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Glucotard (3 x 5 g daily)
Number of subjects: 40
Study: 6693703

Group type: EXPERIMENTAL
Intervention: Clinical pharmacists prescribing drug therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional patient care (Control)
Number of subjects: 0
Study: 31962317

Group type: EXPERIMENTAL
Intervention: Citric acid (0.3%, pH 3.2) for 300 s
Number of subjects: 40

Group type: COMPARATOR
Intervention: Hydrochloric acid (0.01 M, pH 2.38) for 300 s
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Citric acid (0.3%, pH 3.2) for 30 s
Number of subjects: 40

Group type: COMPARATOR
Intervention: Hydrochloric acid (0.01 M, pH 2.38) for 30 s
Number of subjects: 40
Study: 31367875

Group type: EXPERIMENTAL
Intervention: Counseling with care coordination (CCC)
Number of subjects: 606

Group type: COMPARATOR
Intervention: Counseling only (C)
Number of subjects: 606
Study: 29170440

Group type: EXPERIMENTAL
Intervention: Fatigue-inducing hand-grip task for 10 minutes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Viewing the target image
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control images
Number of subjects: 0
Study: 27043327

Group type: EXPERIMENTAL
Intervention: Telemonitoring (TM)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 111
Study: 24679469

Group type: EXPERIMENTAL
Intervention: Guselkumab 10 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Guselkumab 30 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Guselkumab 100 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Guselkumab 300 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Guselkumab (combined doses)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Guselkumab
Number of subjects: 24
Study: 21889833

Group type: EXPERIMENTAL
Intervention: 62 mg tramadol ODT
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: 89 mg tramadol ODT
Number of subjects: 604

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 604
Study: 19178747

Group type: EXPERIMENTAL
Intervention: Intradialytic exercise training (three sessions per week on a cycle ergometer for six months)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Home-based exercise training (walking program to achieve the same weekly physical activity for six months)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 72
Study: 17184435

Group type: EXPERIMENTAL
Intervention: Thiopental 5 mg x kg(‐1) i.v. for children up to 3 years; 2.5 mg x kg(‐1) i.v. rescue boluses if needed.
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Propofol 1-1.5 mg x kg(‐1) i.v. for children over 3 years; maintained with 0.1-0.15 mg x kg(‐1) x min(‐1) continuous i.v. infusion, increased if needed.
Number of subjects: 38
Study: 15184692

Group type: EXPERIMENTAL
Intervention: Leisure-time physical activity (1 SD unit change)
Number of subjects: 4594

Group type: COMPARATOR
Intervention: Control for confounding variables (sex, socioeconomic status, smoking, alcohol consumption, health, appearance, achievement)
Number of subjects: 4594
Study: 11300446

Group type: EXPERIMENTAL
Intervention: Cerivastatin (0.4 mg/d)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 9394873

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 4016

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4016

Group type: COMPARATOR
Intervention: Tricyclic Antidepressant (TCA)
Number of subjects: 4016
Study: 8288357

Group type: EXPERIMENTAL
Intervention: Conventional wood and canvas stretcher
Number of subjects: 60
Study: 3501482

Group type: EXPERIMENTAL
Intervention: Muscular stimulation (MS)
Number of subjects: 10

Group type: COMPARATOR
Intervention: No muscular stimulation (Control)
Number of subjects: 10
Study: 27977223

Group type: EXPERIMENTAL
Intervention: ERRT with nightmare exposure and rescripting (full protocol; EX)
Number of subjects: 70

Group type: COMPARATOR
Intervention: ERRT without nightmare exposure and rescripting (NEX)
Number of subjects: 70
Study: 27388364

Group type: EXPERIMENTAL
Intervention: Low-glycaemic index (GI) diet
Number of subjects: 169

Group type: COMPARATOR
Intervention: High-cereal fibre diet
Number of subjects: 169
Study: 24625229

Group type: EXPERIMENTAL
Intervention: Bioengineered hyaluronic acid (BioHA, 1% sodium hyaluronate) intra-articular injections
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Bioengineered hyaluronic acid (BioHA)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Conventional care (CC) including NSAIDs and analgesics
Number of subjects: 214
Study: 23422634

Group type: EXPERIMENTAL
Intervention: Thyroid collars (TCs) used during cephalometric radiography
Number of subjects: 100

Group type: COMPARATOR
Intervention: No thyroid collars (NTC) used during cephalometric radiography
Number of subjects: 100
Study: 20214822

Group type: EXPERIMENTAL
Intervention: Graduated three layer straight tubular bandaging system (3L)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard short stretch compression bandaging system (SS)
Number of subjects: 0
Study: 18456565

Group type: EXPERIMENTAL
Intervention: Fructose
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Fructans
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Mixture of fructose and fructans
Number of subjects: 25

Group type: COMPARATOR
Intervention: Glucose (Control)
Number of subjects: 25
Study: 15706200

Group type: EXPERIMENTAL
Intervention: Art therapy intervention
Number of subjects: 83

Group type: COMPARATOR
Intervention: Standard hospital services
Number of subjects: 83
Study: 14565628

Group type: EXPERIMENTAL
Intervention: Flite Tabs (150 mg pinokinase)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 204
Study: 11180192

Group type: EXPERIMENTAL
Intervention: CCmax (complete set of Cmax data including subjects with FCM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: TCmax (truncated set of data excluding subjects with FCM)
Number of subjects: 0
Study: 8828022

Group type: EXPERIMENTAL
Intervention: Ebastine 10mg once daily in the morning
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Ebastine 20mg once daily in the morning
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Ebastine 10mg once daily in the evening
Number of subjects: 396

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Ebastine 10mg or 20mg once daily (4-month study)
Number of subjects: 396

Group type: COMPARATOR
Intervention: Placebo (4-month study)
Number of subjects: 396
Study: 1526683

Group type: EXPERIMENTAL
Intervention: Cefodizime (CDZ) 2 g i.v. once daily for seven days
Number of subjects: 20

Group type: COMPARATOR
Intervention: No antibiotic treatment (Control)
Number of subjects: 20
Study: 6360688

Group type: EXPERIMENTAL
Intervention: Diltiazem (D) 282 +/- 102 mg/day
Number of subjects: 70

Group type: COMPARATOR
Intervention: Propranolol (P) 158 +/- 81 mg/day
Number of subjects: 70
Study: 30972793

Group type: EXPERIMENTAL
Intervention: Home OGTT device
Number of subjects: 100

Group type: COMPARATOR
Intervention: Secondary analyser
Number of subjects: 100
Study: 29338462

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 27016862

Group type: EXPERIMENTAL
Intervention: Standardized smoking cessation intervention (physician advice, nicotine replacement therapy, referral to counseling)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Usual care for smoking cessation
Number of subjects: 142
Study: 24880226

Group type: EXPERIMENTAL
Intervention: Modified high-intensity interval training (mHIT)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Usual healthcare (UC)
Number of subjects: 66
Study: 22176806

Group type: EXPERIMENTAL
Intervention: 5% albumin
Number of subjects: 51

Group type: COMPARATOR
Intervention: 0.9% sodium chloride
Number of subjects: 51
Study: 19850697

Group type: EXPERIMENTAL
Intervention: Log-transformed urinary albumin-to-creatinine ratio
Number of subjects: 2131

Group type: COMPARATOR
Intervention: Randomized treatments (n-3 polyunsaturated fatty acids or rosuvastatin)
Number of subjects: 2131
Study: 18069598

Group type: EXPERIMENTAL
Intervention: Angiotensin converting enzyme inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Angiotensin AT1 receptor antagonists
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 0
Study: 15858603

Group type: EXPERIMENTAL
Intervention: Bathing with water only
Number of subjects: 73

Group type: COMPARATOR
Intervention: Bathing with mild pH neutral soap and water
Number of subjects: 73
Study: 12172536

Group type: EXPERIMENTAL
Intervention: Demographic and behavioral characteristics (age ≤19 years, previous abortion, frequency of sexual encounters at least once a week, chlamydial infection)
Number of subjects: 877

Group type: EXPERIMENTAL
Intervention: Combination of 6 or more risk characteristics
Number of subjects: 877
Study: 10023611

Group type: EXPERIMENTAL
Intervention: Therapeutic community treatment
Number of subjects: 46
Study: 7788898

Group type: EXPERIMENTAL
Intervention: Praziquantel at 180 mg/kg bwt for three days
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Albendazole at 90 mg/kg bwt for three days
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Praziquantel at 90 mg/kg bwt plus Albendazole at 45 mg/kg for three days
Number of subjects: 202
Study: 1980930

Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 20

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 20
Study: 7070229

Group type: EXPERIMENTAL
Intervention: 0.005 mg/kg of apomorphine
Number of subjects: 5

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 5
Study: 31248276

Group type: EXPERIMENTAL
Intervention: Homeless individuals
Number of subjects: 547
Study: 30036691

Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS) on acupuncture points Hegu and Zusanli
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham group (placebo)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS)
Number of subjects: 50
Study: 25947278

Group type: EXPERIMENTAL
Intervention: Axxess™ bifurcation stent and BioMatrix™ stents
Number of subjects: 40

Group type: COMPARATOR
Intervention: Culotte technique using XIENCE™ stents
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both strategies
Number of subjects: 40
Study: 24875890

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1 μg/kg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 2 μg/kg
Number of subjects: 90
Study: 24319306

Group type: EXPERIMENTAL
Intervention: Conditional cash transfer (CCT) program, financial incentives ranging from zero to approximately 3-4 months wage
Number of subjects: 0
Study: 19398463

Group type: EXPERIMENTAL
Intervention: Oral clonidine (1 microg/kg every 4 hours)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study: 17453612

Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI) - two 20-minute sessions
Number of subjects: 48

Group type: COMPARATOR
Intervention: Psychoeducation (PE) - one 15-minute session
Number of subjects: 48
Study: 16443607

Group type: EXPERIMENTAL
Intervention: Nebivolol
Number of subjects: 112
Study: 12591004

Group type: EXPERIMENTAL
Intervention: Entrox-coated ALA formulation (6g dose)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Non-coated ALA formulation (6g dose)
Number of subjects: 12
Study: 11194781

Group type: EXPERIMENTAL
Intervention: Annual influenza vaccination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Controlled O2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Corticosteroids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bronchodilators
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Noninvasive positive‐pressure ventilation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antibiotics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined treatment with beta‐agonist and anticholinergic bronchodilators
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chest physiotherapy
Number of subjects: 0
Study: 8858633

Group type: EXPERIMENTAL
Intervention: Intraoperative mitomycin-C (0.1 mg/ml applied for 3 minutes)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Topical mitomycin-C (0.05 mg/ml drops applied for 2 weeks postoperatively)
Number of subjects: 156
Study: 1518497

Group type: EXPERIMENTAL
Intervention: Ofloxacin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional oral antibiotic therapy (non-quinolone)
Number of subjects: 0
Study: 6205676

Group type: EXPERIMENTAL
Intervention: Intralesional injection of 0.1% solution of bleomycin sulphate in normal saline
Number of subjects: 24

Group type: COMPARATOR
Intervention: Normal saline placebo
Number of subjects: 24
Study: 29198993

Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT) with post-exercise milk supplementation
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT) with post-exercise milk-protein supplementation
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT) with post-exercise placebo supplementation
Number of subjects: 53
Study: 28817143

Group type: EXPERIMENTAL
Intervention: Bovine-derived xenograft collagen and collagen membrane
Number of subjects: 20

Group type: COMPARATOR
Intervention: Natural spontaneous healing
Number of subjects: 20
Study: 26654046

Group type: EXPERIMENTAL
Intervention: WAVES study obesity prevention intervention
Number of subjects: 92